Cargando…
Mathematical Prognostic Biomarker Models for Treatment Response and Survival in Epithelial Ovarian Cancer
Following initial standard chemotherapy (platinum/taxol), more than 75% of those patients with advanced stage epithelial ovarian cancer (EOC) experience a recurrence. There are currently no accurate prognostic tests that, at the time of the diagnosis/surgery, can identify those patients with advance...
Autores principales: | Nikas, Jason B., Boylan, Kristin L.M., Skubitz, Amy P.N., Low, Walter C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201114/ https://www.ncbi.nlm.nih.gov/pubmed/22084564 http://dx.doi.org/10.4137/CIN.S8104 |
Ejemplares similares
-
Quantitative proteomic analysis by iTRAQ(® )for the identification of candidate biomarkers in ovarian cancer serum
por: Boylan, Kristin LM, et al.
Publicado: (2010) -
Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4
por: Boylan, Kristin L.M., et al.
Publicado: (2020) -
The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate
por: Boylan, Kristin L.M., et al.
Publicado: (2016) -
A multiplex platform for the identification of ovarian cancer biomarkers
por: Boylan, Kristin L. M., et al.
Publicado: (2017) -
Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
por: Andersen, John D, et al.
Publicado: (2010)